Afghanistan vs Zambia: The number of people with susceptibility test result for rifampicin
Afghanistan
17,443
in 2021
Zambia
16,922
in 2021
Afghanistan rank
16th
Zambia rank
17th
The number of people with susceptibility test result for rifampicin over time
- Afghanistan
- Zambia
How they compare
Afghanistan currently reports 17,443 against 16,922 in Zambia, a difference of 521.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Afghanistan ahead.
Afghanistan ranks 16th and Zambia ranks 17th of 155 countries.
Zambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6,121 | 10,301 | 4,180 | Zambia |
| 2020s | 13,849 | 16,156 | 2,307 | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Afghanistan or Zambia?
- Afghanistan, at 17,443 against 16,922 in Zambia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Afghanistan and Zambia?
- 521, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Zambia?
- 5 years are reported by both, from 2017 to 2021.
- How do Afghanistan and Zambia rank globally for the number of people with susceptibility test result for rifampicin?
- Afghanistan ranks 16th and Zambia ranks 17th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.